Found 5 matching trials
Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage PHASE4 This open, monocentric study is designed to investigate plasma concentratio...
Show More Location
Charité Research Organisation
Learn More & Join Trial
Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis PHASE2 Green tea consists of several components, with most research focusing on th...
Show More Location
University of Louisville Clinical Research Center
Learn More & Join Trial
Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals PHASE1 The purpose of this study is to determine the safety, toxicity, dosing, and...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer PHASE2 RATIONALE: Erlotinib may stop the growth of tumor cells by blocking the enz...
Show More Location
Bladder Cancer Genitourinary Oncology, PC
Learn More & Join Trial
Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers PHASE1 Investigation of systemic catechin exposure following topically administere...
Show More Location
CardioSec Clinical Reasearch GmbH
Learn More & Join Trial